№ files_lp_4_process_3_085080
File format: docx Character count: 5714 File size: 28 KB
Year: 2025
Region / city: United Kingdom
Topic: Vaccination, Gonorrhoea, Meningococcal disease
Document type: Health policy, Vaccine programme
Organization / institution: UK Health Security Agency
Authors: Shamez N Ladhani, Helen Fifer
Target audience: Healthcare professionals, GBMSM at high risk of gonorrhoea
Implementation period: 01 August 2025 - ongoing
Approval date: November 2023
Date of changes: None
Ethics approval: Not applicable
Funding: None
Competing interests: Authors are employees of UKHSA, no conflicts related to the vaccine
Provenance and peer review: Internally peer-reviewed
Note: Document type Official guidance, health policy document
Context: A health policy document outlining the implementation of a meningococcal vaccine programme for individuals at high risk of gonorrhoea in the UK, targeting gay, bisexual, and other men who have sex with men (GBMSM).
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Human papillomavirus vaccine for gay, bisexual, and men who have sex with men (GBMSM) Patient Group Direction (PGD)
Reference no: HPV (GBMSM) PGD
Version no: v5.0
Valid from: 1 September 2025
Review date: 1 April 2028
Expiry date: 1 September 2028
Author: Suki Hunjunt, Sharif Ismail, David Green
Region / city: England
Target audience: Healthcare practitioners administering HPV vaccine to GBMSM
Type of document: Patient Group Direction
Organisation: UK Health Security Agency (UKHSA)
Date of approval: 17 July 2025
Date of modifications: 16 July 2025
Context: A formal Patient Group Direction for the administration of HPV vaccine to GBMSM, detailing legal, clinical, and procedural requirements for healthcare practitioners in England.
Meningococcal Group B (4CMenB) Vaccine for prevention of Gonorrhoea Patient Group Direction (PGD)
Year: 2025
Region / City: England
Topic: Immunisation, Vaccination
Document Type: Patient Group Direction (PGD)
Organization: UK Health Security Agency (UKHSA)
Author: Suki Hunjunt, Professor Shamez Ladhani, David Green
Target Audience: Healthcare practitioners (registered)
Period of validity: 1 August 2025 - 1 August 2027
Approval Date: 9 June 2025
Review Date: 1 February 2027
Amendment Date: 7 July 2025
Meningococcal Group B (4CMenB) Vaccine for prevention of Gonorrhoea Patient Group Direction (PGD)
Year: 2025
Region / City: England
Topic: Immunisation, Vaccination
Document Type: Patient Group Direction (PGD)
Organization: UK Health Security Agency (UKHSA)
Author: Suki Hunjunt, Professor Shamez Ladhani, David Green
Target Audience: Healthcare practitioners (registered)
Period of validity: 1 August 2025 - 1 August 2027
Approval Date: 9 June 2025
Review Date: 1 February 2027
Amendment Date: 7 July 2025
The success of 4CMenB in preventing meningococcal disease: evidence from real world experience
Year: 2020
Region / City: United Kingdom, London
Subject: Meningococcal disease, vaccination
Document Type: Research article
Institution: St George’s University of London, Public Health England
Author: Catherine Isitt, Catherine A Cosgrove, Mary E Ramsay, Shamez N Ladhani
Target Audience: Healthcare professionals, researchers
Period of validity: Ongoing
Date of approval: 2013
Date of modifications: None specified
Topics: GBMSM Gonorrhoea 4CMenB